(Q36826107)

16 August 2017

title

Clinical features and outcomes of cytomegalovirus retinitis after transplantation (English)

1 reference

cytomegalovirus retinitis

16 August 2017

0 references

1 reference

Eid AJ

1

1 reference

16 August 2017

Bakri SJ

series ordinal

2

1 reference

16 August 2017

Kijpittayarit S

series ordinal

3

1 reference

16 August 2017

Razonable RR

series ordinal

4

1 reference

16 August 2017

publication date

19 May 2007

1 reference

Transplant Infectious Disease

16 August 2017

published in

1 reference

16 August 2017

volume

10

1 reference

16 August 2017

issue

1

1 reference

16 August 2017

page(s)

13-18

1 reference

Cytomegalovirus retinitis in immunosuppressed hosts. II. Ocular manifestations

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Virological, clinical, and ophthalmologic features of cytomegalovirus retinitis after hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

A controlled retrospective study of ganciclovir treatment for cytomegalovirus retinopathy. Use of a standardized system for the assessment of disease outcome. UCLA CMV Retinopathy. Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Comparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

Valganciclovir for the prevention and treatment of cytomegalovirus disease in immunocompromised hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2007.00241.X

10.1111/J.1399-3062.2007.00241.X

21 January 2018

Identifiers

DOI

1 reference

16 August 2017

1 reference